Drug Profile
ICT04 CYP
Alternative Names: ICT04-CYPLatest Information Update: 15 Sep 2023
Price :
$50
*
At a glance
- Originator University of Bradford Institute of Cancer Therapeutics
- Developer Incanthera
- Class
- Mechanism of Action Cell death stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Bladder cancer; Colorectal cancer
Most Recent Events
- 15 Sep 2023 Early research is ongoing in Colorectal cancer in UK
- 15 Sep 2023 Early research is ongoing in Bladder cancer in UK
- 28 Aug 2020 No recent reports of development identified for research development in Bladder-cancer in United Kingdom